50% off all subscriptions! ... left. Order NowOrder Now

Corcept Therapeutics Incorporated Stock Forecast NASDAQ:CORT

$21.49 (-4.32%)

Volume: 469k

Closed: Nov 26, 2021

Hollow Logo Score: 0.589

Corcept Therapeutics Incorporated Stock Forecast

$21.49 (-4.32%)

Volume: 469k

Closed: Nov 26, 2021

Score Hollow Logo 0.589
Which way will CORT go? Request
Stop-loss: $20.23 (-5.88%)
Key Stats
P/E Ratio 23.31
Beta 0.8
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 56 and the stock is currently not being overbought or oversold

Red day on Friday for Corcept Therapeutics Incorporated
(Updated on Nov 26, 2021)


Hold candidate since 2021-11-24 Loss -4.32%

The Corcept Therapeutics Incorporated stock price fell by -4.32% on the last day (Friday, 26th Nov 2021) from $22.46 to $21.49. and has now fallen 4 days in a row. During the day the stock fluctuated 5.56% from a day low at $21.41 to a day high of $22.60. The price has fallen in 7 of the last 10 days and is down by -4.7% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 thousand shares and in total, 469 thousand shares were bought and sold for approximately $10.08 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.66% during the next 3 months and, with a 90% probability hold a price between $18.52 and $24.24 at the end of this 3-month period.

Signals & Forecast

The Corcept Therapeutics Incorporated stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $22.68. On a fall, the stock will find some support from the long-term average at approximately $20.68. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, November 22, 2021, and so far it has fallen -7.93%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

Corcept Therapeutics Incorporated finds support from accumulated volume at $20.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.19 between high and low, or 5.56%. For the last week, the stock has had a daily average volatility of 3.58%.

Our recommended stop-loss: $20.23 (-5.88%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)

Is Corcept Therapeutics Incorporated stock A Buy?

Corcept Therapeutics Incorporated holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.589

Predicted Opening Price for Corcept Therapeutics Incorporated of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$21.83 $21.49 (Undervalued)
Hold/Accumulate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Jul 30, 2021 "HC Wainwright" gave "" rating for CORT. The price target was changed from $20.29 to 0.5%.

Volatility and Risk
Daily Average Volatility: 3.58 %
Overall Risk: Very High High Medium Low Very Low
Volatility
3.58 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $21.53
Price: $21.49
Support: $20.51

CORT Insider Trading Show all Trades

INSIDER POWER

1.424

Last 100 transactions
Buy: 4 925 205 | Sell: 3 458 842 (Shares)
Date Action Amount Person Type
Oct 05, 2021 Sell 637 Maduck Sean Stock Option (Right to Buy)
Oct 05, 2021 Sell 24 363 Maduck Sean Stock Option (Right to Buy)
Oct 05, 2021 Buy 637 Maduck Sean Common Stock
Oct 05, 2021 Sell 637 Maduck Sean Common Stock
Oct 01, 2021 Buy 24 363 Maduck Sean Common Stock
Show all Insider Trades
INSIDER POWER

1.424

Last 100 transactions
Buy: 4 925 205 | Sell: 3 458 842 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 23.02 7.14 %
22.57 5.02 %
22.29 3.71 %
Current price: 21.49
Support 21.38 -0.52 %
21.10 -1.82 %
20.64 -3.94 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 22.89 6.51 %
22.49 4.65 %
21.53 0.19 %
Current price 21.49
Support 20.51 -4.56%
19.84 -7.68%
18.24 -15.12%

Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. Its products include Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome, who have type 2 di... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT